Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - paliperidone palmitate 234mg equivalent to 150 mg paliperidone base;   - suspension for injection - 150 mg - active: paliperidone palmitate 234mg equivalent to 150 mg paliperidone base   excipient: citric acid monohydrate dibasic sodium phosphate macrogol 4000 monobasic sodium phosphate monohydrate polysorbate 20 sodium hydroxide water for injection - invega sustenna® is indicated for the acute and maintenance treatment of schizophrenia in adults.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - paliperidone palmitate 39mg equivalent to 25 mg paliperidone base;   - suspension for injection - 25 mg - active: paliperidone palmitate 39mg equivalent to 25 mg paliperidone base   excipient: citric acid monohydrate dibasic sodium phosphate macrogol 4000 monobasic sodium phosphate monohydrate polysorbate 20 sodium hydroxide water for injection - invega sustenna® is indicated for the acute and maintenance treatment of schizophrenia in adults.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - paliperidone palmitate 78mg equivalent to 50 mg paliperidone base;   - suspension for injection - 50 mg - active: paliperidone palmitate 78mg equivalent to 50 mg paliperidone base   excipient: citric acid monohydrate dibasic sodium phosphate dibasic sodium phosphate monohydrate macrogol 4000 polysorbate 20 sodium hydroxide water for injection - invega sustenna® is indicated for the acute and maintenance treatment of schizophrenia in adults.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - paliperidone palmitate 117mg equivalent to 75 mg paliperidone base;   - suspension for injection - 75 mg - active: paliperidone palmitate 117mg equivalent to 75 mg paliperidone base   excipient: citric acid monohydrate dibasic sodium phosphate macrogol 4000 monobasic sodium phosphate monohydrate polysorbate 20 sodium hydroxide water for injection - invega sustenna® is indicated for the acute and maintenance treatment of schizophrenia in adults.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - darunavir ethanolate 162.52mg equivalent to darunavir 150 mg - film coated tablet - 150 mg - active: darunavir ethanolate 162.52mg equivalent to darunavir 150 mg excipient: colloidal silicon dioxide crospovidone magnesium stearate opadry white 85f18422 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - darunavir ethanolate 433.64mg equivalent to darunavir 400 mg - film coated tablet - 400 mg - active: darunavir ethanolate 433.64mg equivalent to darunavir 400 mg excipient: colloidal silicon dioxide crospovidone magnesium stearate opadry orange 85f93377 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - darunavir ethanolate 650.46mg equivalent to darunavir 600 mg - film coated tablet - 600 mg - active: darunavir ethanolate 650.46mg equivalent to darunavir 600 mg excipient: crospovidone magnesium stearate opadry orange 85f13962 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - darunavir ethanolate 81.31mg equivalent to darunavir 75 mg - film coated tablet - 75 mg - active: darunavir ethanolate 81.31mg equivalent to darunavir 75 mg excipient: colloidal silicon dioxide crospovidone magnesium stearate opadry white 85f18422 purified water silicified microcrystalline cellulose - adult patients: prezista (with low dose ritonavir as a pharmacokinetic enhancer) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adult patients.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - infliximab 100mg;   - powder for injection - 100 mg - active: infliximab 100mg   excipient: dibasic sodium phosphate dihydrate monobasic sodium phosphate monohydrate polysorbate 80 sucrose - rheumatoid arthritis remicade is a ?disease-controlling anti-rheumatic therapy" (dcart) indicated for: · the reduction of signs and symptoms · prevention of structural joint damage (erosions and joint space narrowing) · improvement in physical function in patients with active disease. remicade should be given in combination with methotrexate.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - risperidone 0.25mg;  ;   - film coated tablet - 0.25 mg - active: risperidone 0.25mg     excipient: colloidal silicon dioxide hypromellose e-15 hypromellose e-5 iron oxide yellow lactose monohydrate magnesium stearate maize starch microcrystalline cellulose propylene glycol purified talc sodium laurilsulfate titanium dioxide